Anaphylactic reactions to isosulfan blue dye during sentinel node lymphadenectomy for breast cancer

Anesthesia and Analgesia

Volumn 96, Issue 4, 2003, Pages 1051-1053

  Sprung, Juraj ^a,c   Tully, Michael J ^a   Ziser, Avishai ^b  

^a MAYO CLINIC   (United States)

^b RAMBAM MEDICAL CENTER   (Israel)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DEXAMETHASONE; EPHEDRINE; GLYCOPYRRONIUM BROMIDE; ISOSULFAN BLUE; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; ANAPHYLAXIS; ARTICLE; BREAST CANCER; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; HUMAN; LYMPHADENECTOMY; PRIORITY JOURNAL; SENTINEL LYMPH NODE; TREATMENT OUTCOME;

EID: 0037377898     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000048709.61118.52     Document Type: Article

References (15)

1. Sadiq TS, Burns WW 3rd, Taber DJ, et al. Blue urticaria: a previously unreported adverse event associated with isosulfan blue. Arch Surg 2001;136:1433-5.
2. Cimmino VM, Brown AC, Szocik JF, et al. Allergic reactions to isosulfan blue during sentinel node biopsy: a common event. Surgery 2001;130:439-42.
3. Woltsche-Kahr I, Komericki P, Kranke B, et al. Anaphylactic shock following peritumoral injection of patent blue in sentinel lymph node biopsy procedure. Eur J Surg Oncol 2000;26:313-4.
4. Longnecker SM, Guzzardo MM, Van Voris LP. Life-threatening anaphylaxis following subcutaneous administration of isosulfan blue 1%. Clin Pharm 1985;4:219-21.
5. Leong SP, Donegan E, Heffernon W, et al. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol 2000;7:361-6.
6. Albo D, Wayne JD, Hunt KK, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 2001;182:393-8.
7. Montgomery LL, Thorne AC, Van Zee KJ, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg 2002;95:385-8.
8. Coleman RL, Whitten CW, O'Boyle J, Sidhu B. Unexplained decrease in measured oxygen saturation by pulse oximetry following injection of Lymphazurin 1% (isosulfan blue) during a lymphatic mapping procedure. J Surg Oncol 1999;70:126-9.
9. Schwartz LB, Metcalfe DD, Miller JS, et al. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987;316:1622-6.
10. Schwartz LB. Tryptase, a mediator of human mast cells. J Allergy Clin Immunol 1990;86:594-8.
11. Cody HS 3rd, Fey J, Akhurst T, et al. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol 2001;8:13-9.
12. Kuerer HM, Wayne JD, Ross MI. Anaphylaxis during breast cancer lymphatic mapping. Surgery 2001;129:119-20.
13. Laurie SA, Khan DA, Gruchalla RS, Peters G. Anaphylaxis to isosulfan blue. Ann Allergy Asthma Immunol 2002;88:64-6.
14. Lyew MA, Gamblin TC, Ayoub M. Systemic anaphylaxis associated with intramammary isosulfan blue injection used for sentinel node detection under general anesthesia. Anesthesiology 2000;93:1145-6.
15. Kuerer HM, Hunt KK, Singletary SE, Ames FC. Unusual aspects of breast cancer: case 3-blue hives during lymphatic mapping for breast cancer. J Clin Oncol 2001;19:2573-4.